The weekly litigation news digest is live. Subscribe now

IP Verse

Treatment Of Gout And Hyperuricemia - EP2582683

The patent EP2582683 was granted to Ardea Biosciences on Mar 21, 2018. The application was originally filed on Jun 14, 2011 under application number EP11796324A. The patent is currently recorded with a legal status of "Revoked".

EP2582683

ARDEA BIOSCIENCES
Application Number
EP11796324A
Filing Date
Jun 14, 2011
Status
Revoked
Aug 7, 2020
Publication Date
Mar 21, 2018
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

BULLE DRDec 21, 2018HOEFER & PARTNER PATENTANWALTE MBBADMISSIBLE
HEXALDec 21, 2018TER MEER STEINMEISTER & PARTNERADMISSIBLE
ALFRED E TIEFENBACHERDec 20, 2018HAMM & WITTKOPPADMISSIBLE

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS20090554719
DESCRIPTIONUS2009197825
DESCRIPTIONWO2009070740
EXAMINATIONWO2009070740
INTERNATIONAL-SEARCH-REPORTWO2010028190
INTERNATIONAL-SEARCH-REPORTWO2011085009
OPPOSITIONUS2006270725
OPPOSITIONUS2010056464
OPPOSITIONUS2010160351
OPPOSITIONWO2006026356
OPPOSITIONWO2007050087
OPPOSITIONWO2009070740
OPPOSITIONWO2010028190
OPPOSITIONWO2012050589

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents